In these data sets, ARHGAP29 mRNA expression appeared enriched in glomerular diseases usually presenting with milder damage patterns such as hypertensive nephropathy (HTN) and minimal change disease (MCD). This evidence concerns the gene ARHGAP29 and lipoid nephrosis.